Mid-term outcomes of the COMMENCE trial investigating mitral valve replacement using a bioprosthesis with a novel tissue.

David A Heimansohn,Craig Baker,Evelio Rodriguez,Hiroo Takayama,Francois Dagenais, David S Talton,Mubashir A Mumtaz,Philippe Pibarot,John D Puskas

JTCVS open（2023）

引用 0|浏览2

暂无评分

摘要

Mitral valve replacement patients implanted with a RESILIA tissue bioprosthesis had a good safety profile and clinically stable hemodynamic performance.

查看译文

关键词

mitral valve replacement,bioprosthesis,mid-term

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要